CliffBio
small molecule

BALCOLTRA

ETHINYL ESTRADIOL; LEVONORGESTREL

Loss of exclusivityJune 2027latest FDA-listed patent expiry
CompanyAvion Pharmaceuticals →View the full company profile on CliffBio

Drug detail

Brand nameBALCOLTRA
Active ingredientETHINYL ESTRADIOL; LEVONORGESTREL
Strength0.02MG;0.1MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalJanuary 2018
Marketing statusRX

Listed patents

PatentExpiresType
7838042June 2027substance

More from Avion Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

BALCOLTRA patent cliff — loss of exclusivity June 2027 | CliffBio